Related Experiment Video

Updated: Aug 12, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
11:40

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

[Clinical and therapeutic observations on 34 cases of meningococcic meningitis]

V Gorgan, M Gidaly, I Serban

    Revista De Igiena, Bacteriologie, Virusologie, Parazitologie, Epidemiologie, Pneumoftiziologie. Bacteriologia, Virusologia, Parazitologia, Epidemiologia
    |January 1, 1975
    PubMed

    Insights

    Meningococcal meningitis predominantly affected adolescents and young adults, with all 34 patients recovering fully. Penicillin G monotherapy proved as effective as combination therapies for this bacterial meningitis.

    Area of Science:

    • Infectious Diseases
    • Bacteriology
    • Clinical Medicine

    Context:

    • Meningococcal meningitis remains a significant public health concern, particularly in younger populations.
    • This study analyzes 34 cases admitted over three years to a communicable disease clinic.
    • Understanding treatment outcomes and antimicrobial resistance patterns is crucial for effective management.

    Purpose:

    • To report on the clinical characteristics and treatment outcomes of meningococcal meningitis cases.
    • To evaluate the efficacy of different therapeutic regimens, including penicillin G monotherapy and combination therapies.
    • To assess the antimicrobial susceptibility of Neisseria meningitidis isolates.

    Summary:

    • A total of 34 patients with meningococcal meningitis were treated, with the highest incidence observed in adolescents and young adults (76%).
    • All patients recovered within 9-12 days without sequelae or relapses, irrespective of treatment (penicillin G alone or with sulfonamides, chloramphenicol, ampicillin, and/or corticosteroids).
    • A notable decrease in meningococcal sensitivity to sulfonamides and chloramphenicol, and increased resistance to tetracycline and erythromycin were observed.

    Impact:

    • The findings support penicillin G as an effective primary treatment for meningococcal meningitis.
    • The study highlights evolving antimicrobial resistance patterns, necessitating ongoing surveillance and potential treatment guideline adjustments.
    • This research contributes to the clinical understanding and management strategies for bacterial meningitis.

    More Related Videos

    Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

    Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

    Published on: November 5, 2019

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

    Published on: May 7, 2020

    Related Concept Videos

    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...